BOT 1.41% 35.0¢ botanix pharmaceuticals ltd

Ann: Investor Webinar Presentation, page-48

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,049 Posts.
    lightbulb Created with Sketch. 135
    This presentation exudes a huge amount of confidence on successful FDA approval for SB. Howie says he has sales reps already banging on his door wanting to be a part of this, so that indicates confidence in not only Howie but the product. They are clearly well ahead of the game.

    It appears just on SB alone, the tide has been turned back because management are now over delivering on progress. We have clearly put the debacle on BTX1503 behind us and this pending SB approval will change the company for the better and for a very long time.


    It has been a huge learning curve for all, but this presentation is not over hyped, it maps a very clear direction for the launch, it explains the possibilties of early approval and therefore is very exciting.
    They know that approval is extremely likley and so do the powers that be manipulating the shareprice. I don't think it is lack of shareholder confidence holding this down at all, but just rotation between accounts which creates a false perception,which in turns shakes weak hands. Handy for those who can see for what it is. Admittedly some of the recent 9c cap raise holders showed a real lack of understanding or were just there as a ready to go ATM.

    The outcome here is staring everyone in the face and the current shareprice in a couple of months will feel like we have bought a new car with pocket money.
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.